Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
- Corporate and Finance
Aug 1, 2019
Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023
- Corporate and Finance
May 10, 2019
Novavax Announces Reverse Stock Split of Common Stock
- Corporate and Finance
May 8, 2019
Novavax Reports First Quarter 2019 Financial Results
- Corporate and Finance
May 2, 2019
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019
- Corporate and Finance
Apr 25, 2019
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
- Corporate and Finance
Mar 18, 2019
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019
- Corporate and Finance
Mar 11, 2019
Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference
- Corporate and Finance
Jan 2, 2019
Novavax Announces Leadership Promotions
- Corporate and Finance
Dec 4, 2018
Novavax Expands Leadership with Several Key Management Promotions
- Corporate and Finance
Nov 12, 2018
Novavax Reports Third Quarter 2018 Financial Results
- Corporate and Finance
Nov 7, 2018
Novavax Appoints Rachel King to Board of Directors
- Corporate and Finance
Nov 1, 2018
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
- Corporate and Finance
Nov 1, 2018
Novavax to Present at Two Upcoming Investor Conferences
- Corporate and Finance
Sep 26, 2018
Novavax to Participate at Two Upcoming Investor Conferences
- Corporate and Finance
Aug 28, 2018
Novavax Reports Second Quarter 2018 Financial Results
- Corporate and Finance
Aug 8, 2018
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018
- Corporate and Finance
Aug 1, 2018
Novavax CEO to Discuss Future of Global Vaccine Business as Part of Panel of Industry Leaders at 2018 BIO International Convention
- Corporate and Finance
May 31, 2018
Novavax Reports First Quarter 2018 Financial Results
- Corporate and Finance
May 9, 2018
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018
- Corporate and Finance
May 2, 2018
Novavax Announces Closing of Public Offering
- Corporate and Finance
Apr 16, 2018
Novavax Announces Proposed Public Offering of Common Stock
- Corporate and Finance
Apr 11, 2018
Novavax Prices Public Offering of Common Stock
- Corporate and Finance
Apr 11, 2018
Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer
- Corporate and Finance
Mar 14, 2018
Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
- Corporate and Finance
Mar 14, 2018

Show per page